Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dobutamine Hydrochloride for Injection

Approval Number

国药准字H20020133

Company江苏联环药业股份有限公司

Registration Date

August 21, 2020

Drug Information

Generic Name

注射用盐酸多巴酚丁胺

Trade Name

奥万源

Dosage Form

注射剂

Strength

20mg(以C18H23NO3计)

Drug Type

化学药品

Registration Date

August 21, 2020

Company Information

Applicant Company

Company Name江苏联环药业股份有限公司

Manufacturing Company

Company Name江苏联环药业股份有限公司

Company Address

扬州市生物健康产业园健康一路9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy